TIAA CREF Investment Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $19.4M | Buy |
38,558
+12,605
| +49% | +$6.35M | 0.01% | 719 |
|
2018
Q4 | $12.8M | Sell |
25,953
-2,703
| -9% | -$1.33M | 0.01% | 836 |
|
2018
Q3 | $26.2M | Buy |
28,656
+869
| +3% | +$795K | 0.02% | 631 |
|
2018
Q2 | $20.4M | Sell |
27,787
-15,173
| -35% | -$11.1M | 0.01% | 738 |
|
2018
Q1 | $68.5M | Buy |
42,960
+1,260
| +3% | +$2.01M | 0.05% | 367 |
|
2017
Q4 | $37.4M | Buy |
41,700
+4,767
| +13% | +$4.27M | 0.02% | 534 |
|
2017
Q3 | $13.3M | Sell |
36,933
-1,408
| -4% | -$507K | 0.01% | 978 |
|
2017
Q2 | $11.2M | Sell |
38,341
-10,667
| -22% | -$3.13M | 0.01% | 1061 |
|
2017
Q1 | $17.3M | Buy |
49,008
+8,984
| +22% | +$3.16M | 0.01% | 814 |
|
2016
Q4 | $7.37M | Buy |
40,024
+2,557
| +7% | +$471K | 0.01% | 1329 |
|
2016
Q3 | $9.66K | Sell |
37,467
-592
| -2% | -$153 | 0.01% | 1141 |
|
2016
Q2 | $8.12M | Sell |
38,059
-1,396
| -4% | -$298K | 0.01% | 1193 |
|
2016
Q1 | $8.14M | Sell |
39,455
-601
| -2% | -$124K | 0.01% | 1176 |
|
2015
Q4 | $10.1M | Sell |
40,056
-621
| -2% | -$157K | 0.01% | 1062 |
|
2015
Q3 | $6.69M | Sell |
40,677
-1,392
| -3% | -$229K | 0.01% | 1334 |
|
2015
Q2 | $7.89M | Sell |
42,069
-6,206
| -13% | -$1.16M | 0.01% | 1331 |
|
2015
Q1 | $7.97M | Sell |
48,275
-309
| -0.6% | -$51K | 0.01% | 1304 |
|
2014
Q4 | $11.3M | Sell |
48,584
-1,634
| -3% | -$380K | 0.01% | 1037 |
|
2014
Q3 | $9.09M | Sell |
50,218
-885
| -2% | -$160K | 0.01% | 1155 |
|
2014
Q2 | $9.83M | Buy |
51,103
+1,575
| +3% | +$303K | 0.01% | 1173 |
|
2014
Q1 | $9M | Buy |
49,528
+997
| +2% | +$181K | 0.01% | 1205 |
|
2013
Q4 | $8.26M | Sell |
48,531
-229
| -0.5% | -$39K | 0.01% | 1275 |
|
2013
Q3 | $7.64M | Sell |
48,760
-651
| -1% | -$102K | 0.01% | 1265 |
|
2013
Q2 | $8.56M | Buy |
+49,411
| New | +$8.56M | 0.01% | 1145 |
|